Loading...
PEGA is not a good buy right now. The stock is extremely oversold (RSI_6 ~15) and sitting near support, which can produce a short-term bounce, but the prevailing momentum remains bearish (MACD histogram negative and expanding) and there is no Intellectia buy signal to prioritize. With insiders actively selling and the trend still pointed down, the risk/reward for an impatient entry is not attractive despite supportive options sentiment and a bullish Street target reset.
Trend/Momentum: Bearish-to-weak. The MACD histogram (-0.849) is below zero and expanding negatively, signaling downside momentum is still building.
Mean-reversion setup: RSI_6 at 15 indicates deeply oversold conditions, which often precede short-lived rebounds, but oversold is not a timing trigger by itself when MACD is still deteriorating.
Levels: Price (44.1–44.6 pre-market/current options snapshot) is around S1 (44.958) and above S2 (41.845), with pivot resistance much higher (49.996). This positioning suggests the stock is testing support; a bounce would need to reclaim ~45–50, while a failure of support opens room toward ~41.8.
MA picture: Converging moving averages imply consolidation, but not yet a confirmed reversal.

increases odds of a near-term reflex bounce from support.
and pressing key support near ~45; a breakdown increases downside risk toward ~41.
Latest quarter: 2025/Q3.
Recent Wall Street change: On 2025-12-05, JPMorgan raised its price target to $74 (from $65) and maintained Overweight, highlighting cloud migration, legacy transformation demand, and subscription-model predictability. Pros view: Durable enterprise modernization tailwinds + more predictable subscription revenue profile. Cons view: Recent profitability volatility (net income/EPS YoY decline) and current bearish price momentum reduce confidence in buying immediately. Influential/political trading: No recent Congress trading data available; no politician activity provided. Intellectia Proprietary Trading Signals: